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Antibody-based analysis reveals “filamentous vs. 
non-filamentous” and “cytoplasmic vs. nuclear” crosstalk of 
cytoskeletal proteins 
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To uncover the molecular composition and dynamics of the functional scaffold for the nucleus, three fractions of 
biochemically-stable nuclear protein complexes were extracted and used as immunogens to produce a variety of 
monoclonal antibodies. Many helix-based cytoskeletal proteins were identified as antigens, suggesting their 
dynamic contribution to nuclear architecture and function. Interestingly, sets of antibodies distinguished distinct 
subcellular localization of a single isoform of certain cytoskeletal proteins; distinct molecular forms of keratin and 
actinin were found in the nucleus. Their nuclear shuttling properties were verified by the apparent nuclear 
accumulations under inhibition of CRM1-dependent nuclear export. Nuclear keratins do not take an obvious 
filamentous structure, as was revealed by non-filamentous cytoplasmic keratin-specific monoclonal antibody. These 




* A set of monoclonal antibodies were raised against nuclear scaffold proteins 
* Helix-based cytoskeletal proteins were involved in nuclear scaffold 
* Many cytoskeletal components shuttle into the nucleus in a CRM1-dependent manner 
* Sets of antibodies distinguished distinct subcellular localization of a single isoform 
* Nuclear keratin is soluble and does not form an obvious filamentous structure 
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The existence of functional scaffold in the nucleus has 
been long debated based on the results of several 
different methodologies. Observation of chromatin- 
depleted cell nucleus by electron microscope revealed 
a network of branched 10-nm fibers distributed 
throughout the nucleoplasmic space [1]. Biochemical 
fractionation techniques have been developed to 
uncover the structural basis of the nuclear organization 
by sequential elution of soluble proteins [2]. As an 
outcome of this step-by-step dissection, 80-nm beaded 
fibers were observed in high-salt extracted nucleus, 
and 10- to 20-nm thin fibers along with 500- to 
750-nm large lobes were observed in chromatin- 
depleted nucleus by atomic force microscopy [3]. 
Recent proteomic studies have identified the protein 
composition of nuclear structures resistant to 
biochemical treatments [4-6]. More than 400 proteins 
were identified, including many novel and 
uncharacterized proteins such as BXDC1 (brix-domain 
containing 1), EBNA1BP2 (EBNA 1 binding protein 
2), and Caprice (C19orf21). This implies that 
previously limited understanding of biochemically 
stable protein complexes obtained by normal 
molecular biology approach is due to their highly 
insoluble properties. 
 Various cytoskeletal proteins have been 
found to shuttle between the cytoplasm and the nucleus 
and to play a role in nuclear-specific events such as 
transcription, DNA repair and nuclear body formation 
[7]. Two typical examples of such proteins are nuclear 
actin and β-catenin, which are indispensable for RNA 
polymerases and chromatin remodeling [8] and for 
transmitting Wnt signal into the nucleus [9], 
respectively. Another example identified in our group 
is cell cycle-dependent nuclear accumulation of an 
actin-binding cytoskeletal protein actinin-4 and its 
interaction with the INO80 chromatin-remodeling 
complex [10]. Such findings imply that nucleus and 
cytoplasm are closely linked by the nuclear shuttling of 
scaffold components. Interestingly, in spite of those 
shuttling proteins’ crucial role in the nucleus, they 
often do not exhibit apparent nuclear localization and 
are dominantly localized to the cytoplasm. 
 In this study, we have raised a variety of 
monoclonal antibodies against crude nuclear 
scaffolding proteins prepared by biochemical 
fractionation of the cells. Molecular analyses using 
these monoclonal antibodies indicate a close 
relationship between cytoskeletal proteins and nuclear 
scaffold, including a CRM1-dependent nuclear 
localization of non-filamentous keratins, and provide 




Materials and Methods 
 
Preparation of immunogen, immunization, and 
cloning of hybridoma 
 
Mitotic chromosomal proteins were a gift from Dr. K. 
Fukui, which were isolated as previously described 
[11]. High-salt extraction fraction and highly insoluble 
fractions were prepared based on the method described 
previously [2], by the sequential treatments of HeLa S3 
cells with buffer A (10 mM PIPES-NaOH (pH 6.8), 
100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM 
EGTA, 0.5% Triton X-100, 1 mM PMSF, and 1:100 
protease inhibitor cocktail (Nacalai Tesque)), buffer B 
(10 mM PIPES-NaOH (pH 6.8), 250 mM (NH4) 2SO4, 
300 mM sucrose, 3 mM MgCl2, 1 mM EGTA, 0.5% 
Triton X-100, 1 mM PMSF, and 1:100 protease 
inhibitor cocktail (Nacalai Tesque)), and buffer C 
(10U/μl deoxyribonuclease I (DNase I) in 10 mM 
PIPES-NaOH (pH 6.8), 50 mM NaCl, 300 mM sucrose, 
3 mM MgCl2, 1 mM EGTA, 0.5% Triton X-100, 1mM 
PMSF, and 1:100 protease inhibitor cocktail (Nacalai 
Tesque)). 
 The immunization and cell fusion processes 
were performed at Immuno-Biological Laboratories 
(IBL) and Takara Bio. BALB/c mice were immunized 
by intradermal and subcutaneous injections. After 4 
and 8 weeks, the immunoreactivities of the antisera 
were examined by enzyme-linked immunosorbent 
assay (ELISA), immunoblot and immunofluorescence 
microscopy. A mouse with the highest titer was chosen 
for making hybridoma cells. The spleen cells were 
harvested and fused with myeloma cells (X-63Ag8) by 
PEG-mediated method. The fused hybridoma cells 
were cultured in TIL medium (IBL) supplemented with 
10% fetal bovine serum in 5% CO2 at 37°C. The cells 
were cloned by limited dilution and the culture media 
were subjected to screening by immunostaining of 
HeLa cells. Positive clones were selected and further 
cultured. 
 
Immunostaining and microscopic observation 
 
HeLa cells were treated with buffer A for 15 minutes or 
20 ng/ml leptomycin B (Calbiochem) for 4 hours. The 
cells were washed twice with PBS and then fixed with 
4% paraformaldehyde (PFA) in PBS at room 
temperature for 15 minutes. The sample was blocked 
with 5% normal goat serum for 15 minutes, and then 
incubated with the primary antibody. For both 
non-treated and LMB-treated cells, 0.5% Triton X-100 
was added to the blocking buffer for permeabilization. 
The specific binding was detected by FITC-conjugated 
anti-mouse IgG (Cappel) or anti-rabbit IgG (Cappel). 
If necessary, the sample was stained with hoechst 
33342 or propidium iodide (PI) (5 µg/ml) in the 
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mounting medium (Vectashield). Microscopic 
observations and fluorescent recovery assays were 
performed at room temperature using a confocal laser 
scanning microscopes (LSM 5 PASCAL, Carl Zeiss, 
and FV-1200, Olympus) with ×63 Plan-Apo objective 
lens N.A. =1.4. 
 
cDNA constructs and recombinant proteins 
 
Complementary DNA for actinin-4, βI-spectrin, 
keratin-7, -8, -17, -18, and vimentin were amplified 
from HeLa cDNA pool reverse transcribed by 
SuperScript II reverse transcriptase (Invitrogen) from 
total RNA extracted by RNeasy RNA extraction kit 
(Qiagen). The cDNAs were cloned into pEGFP-C1 
vector (Clontech) and transformed into HeLa cells by 
Effectene transfection reagent (Qiagen) according to 
the manufacturer’s instructions. For bacterial 
expression, the cDNAs were cloned into pGEX-6P 
vector (GE) and expressed in BL21RIL E. coli. 
 
cDNA expression library screening 
 
The expression library screening was performed by 
using Lambda-ZAP HeLa cDNA expression library 
(Stratagene-Agilent) according to the manufacturer’s 
instructions. After transferring the expression library 
onto the PVDF membrane, conditioned media from 
hybridoma cells were used for immunoblotting 
followed by alkaline phosphatase-conjugated 
anti-mouse IgG (Nacalai Tesque) and detection by 
nitro blue tetrazolium/3-bromo-4-chloro-5-indolyl 
phosphate reagent. The phage isolation step was 
repeated several times to obtain a single clone. The 
isolated cDNA was identified by an automated DNA 




HeLa cells were resuspended in RIPA buffer (50 mM 
Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.1% 
SDS, 0.1% deoxycholate, 1% Triton X-100 and 1:100 
protease inhibitor cocktail (Nacalai Tesque)) and 
sonicated. After centrifugation at 15,000 rpm 
(20,400×g) for 10 minutes, the supernatant was 
collected. The antibody for the assay was incubated 
with Dynabeads Protein A (Veritas) at 4°C for 6 hours. 
Antibody-coated beads were incubated with the 
supernatant at 4°C overnight. The collected beads were 
washed five times with the RIPA buffer, and applied to 
SDS-PAGE followed by Coomassie Brilliant Blue 




Nuclear matrix fraction (8.8 mg) and S2 fraction (12 
mg) extracted from HeLa cells were solubilized with 
5% SDS supplemented with 2-mercaptoethanol (1: 20, 
v/v), and heated at 100°C for 5 minutes. After cooling, 
the solution was supplemented with final 90% (v/v) 
formic acid, diluted with an equal volume of solvent A 
(60% formic acid), and centrifuged at 6,500×g for 10 
minutes. The supernatant was applied to a 10 μm 
polystyrene Poros 10 R1 column (7.5 mm × 75 mm; 
PerSeptive Biosystem, Cambridge) equilibrated with 
solvent A. The proteins were then eluted with a 0 to 
35% linear gradient of solvent B (33% n-butanol in 
60% formic acid) for 140 minutes. The concentration 
of solvent B was increased to 45% in 10 minutes, then 
increased to 100% in 5 minutes, and was kept at 100% 
for 20 minutes. All the steps were performed at 1.5 
ml/minute flow-rate at room temperature. The aliquots 
of the sample were concentrated with a centrifugal 
concentrator. Before the sample was completely dry, 
200 μl of water was added, and the drying was 
continued. This step was repeated three times. The 
pellets were solubilized with 10% SDS containing 20 
mM Tris-HCl (pH 9.0) and 10 mM dithiothreitol, and 
applied to SDS-PAGE. 
 
In gel digestion 
 
The SDS-PAGE gels were stained with CBB and the 
excised target bands were cut into small pieces. The 
gel pieces were destained with 50% acetonitrile in 50 
mM ammonium bicarbonate for 10 minutes at 37°C, 
and sequentially incubated in 100% acetonitrile and 
water, until CBB faded out completely (3-5 cycles). 
The gel pieces were then dried in a centrifugal 
concentrator and rehydrated by 8 μg/ml trypsin 
(Promega) in 17 mM ammonium bicarbonate. After the 
trypsin solution was completely absorbed into the gel 
pieces, minimum amount of 50 mM ammonium 
bicarbonate was added and incubated for 16 hours at 
37°C. The tryptic peptides were extracted twice with 
50 μl of acetonitrile/water/trifluoroacetic acid solution 
(66:33:0.1, v/v) in a sonicator for 10 minutes. The gel 
pieces were finally dehydrated for 10 minutes with 50 
μl of acetonitrile, which was also collected and 
combined with the extract. The combined extracts were 
dried at 50°C in a centrifugal concentrator. 
 
Protein identification by matrix-assisted laser 
desorption ionization-time of flight mass 
spectrometry (MALDI-TOF MS) 
 
Mass spectra data of tryptic peptides were obtained by 
using a MALDI-TOF MS (AXIMA-CFR; Shimadzu 
Biotech, Kyoto) in the positive ion reflectron mode. 
-Cyano-4-hydroxycinnamic acid was used as a matrix. 
The corrected mass lists were used as peptide mass 
fingerprinting data for search in databases. Mascot 
search engine (Matrix Science) was used to identify 
the protein by searching in entries under the Homo 
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sapience category of the SwissProt databases using the 
assumptions that peptides are monoisotopic and 
carbamidomethylated at cysteine residues. Up to one 
missed trypsin cleavage was allowed. Mass tolerance 
of 0.5 Da for monoisotopic data was set as the window 
of error allowed for matching the peptide mass values. 
Proteins matched with probability value less than 0.05 
by probability-based MOWSE score provided from 
MASCOT were considered to be identified with high 
reliability. 
 
Protein identification by liquid chromatgography- 
MS/MS (LC-MS/MS) 
 
The tryptic peptides were analyzed with a nanoflow 
LC-iontrap-tandem mass spectrometer 
(nLC-IT-MS/MS, Agilent 1100 LC/MSD Trap XCT 
Ultra) equipped with an enrichment column (0.3 x 5 
mm, ZORBAX 300 SB-C18, 5 μm), an analytical 
column (0.075 x 150 mm, ZORBAX 300 SB-C18, 3.5 
μm), and a spray needle. The peptides were eluted with 
solvent C (0.1% formic acid) and solvent D 
(acetonitrile containing 0.1% formic acid), by a 30 
minutes linear gradient from 2% to 50% solvent D, 
followed by 50% solvent D isocratic run for 10 
minutes and subsequent 80% solvent D isocratic run 
for 10 minutes, at a flow rate of 300 nl/minute. The 
mass spectrometer was operated in positive ion mode 
over the range of 350-1800 m/z in the data-dependent 
mode to select the three most intense precursor ions for 
acquisition of MS/MS spectra. The identification of 
proteins was performed with Spectrum Mill MS 
Proteomics Workbench platform (version A.03.02; 
Agilent Technologies). The data analysis was 
performed with the following parameters: fixed 
modification, carbamidomethylation; MH+ range, 
600-4000 Da; sequence tag length, more than 1; 
window setting of merging spectra from the same 
precursor, retention time within ±15 s and mass value 
within ±1.4 m/z; maximum charge, +7; minimum S/N, 
25. The extracted and processed MS spectra were 
searched against the in-house built IPI human protein 
database. Carbamidomethylation was set as fixed 
modification, and oxidized methionine as variable 
modification. Mass tolerance was ±2.5 Da on MS 
peaks and ±0.7 Da on MS/MS peaks. Two missed 
cleavages with trypsin were allowed. The instrument 
setting was specified as electrospray ionization (ESI) 
ion trap. Proteins with more than two plausible 
peptides matches (the peptide score more than 6 and 
SPI more than 70%) were considered to be identified. 
 
 
Fig. 1 Overview of the experiments and preparation of immunogen. 
Three fractions of biochemically-stable nuclear structural protein complexes, i.e., Mitotic Chromosomes, S2 
and Pellet, were extracted and used as immunogens. Hybridoma cells were screened by immunofluorescence 
and cloned by limiting dilution. Antigens for each monoclonal antibody were identified by cDNA expression 




Fig. 2 Immunostaining of HeLa cells by a set of monoclonal antibodies. 
(A-H) HeLa cells grown on a cover glass were fixed with 4% PFA and subjected to immunostaining with the 
culture media of monoclonal hybridomas. The immunosignals were found in a variety of subcellular 
compartments: nucleus, nucleolus, nuclear membrane, nuclear speckles, and cytoplasmic substructures. Scale 
bars: 10 µm. Antibody ID: (A) 2-30C, (B) 3-81A2, (C) 45A, (D) 1-67D, (E) 58A, (F) 90A, (G) 54I, (H) 2-40D. 
(I) Summary of the immunostaining results of HeLa cells fixed with 4% PFA. (J) Summary of the 
immunostaining of HeLa cells treated with buffer containing 0.5% Triton X-100 before fixation. 
Fig. 3 Characteristic localizations of antigens revealed by immunostaining of HeLa cells. 
(A,B) Antigens localized to more than two subcellular compartments: nuclear speckle and cytoplasm (A; 31C), 
nucleoplasm, cytoplasm and subnuclear compartment (B; 2-63A). (C-E) Antigens which showed more than two 
biochemically-distinctive molecular populations by buffer A treatment. Antibody ID: (C) 15D-D, (D) 36C, (E) 
1-93A. WC: immunofluorescence staining of whole cells fixed with PFA, Det: cells treated with buffer A before 






Monoclonal antibody-based approach to the 
analysis of biochemically-stable nuclear scaffold 
 
Using the three fractions of nuclear structural proteins 
extracted from cultured cells as immunogens (Fig. 1), 
we aimed to obtain several different monoclonal 
antibodies against nuclear scaffold proteins, with the 
goal of producing specific antibodies that recognize 
distinct states of the antigen. After a limiting dilution 
of the obtained hybridomas, the first screening was 
performed by ELISA, and culture media were 
collected for immunofluorescence microscopy. Some 
of the beautiful and intriguing staining patterns are 
shown in Fig. 2. Half of the antibodies recognized 
nuclear structures and the rest recognized cytoplasmic 
structures (Fig. 2I). Some of the antibodies showed 
immunosignals in more than two distinctive 
subcellular compartments (Fig. 3A,B). Among the 
nuclear antibodies, a quarter of them were also found 
to recognize cytoplasmic structures, which indicated 
the role of such structural proteins in both the 
cytoplasm and the nucleus. When the cells were 
pre-treated with the buffer containing 0.5% Triton 
X-100 to remove highly soluble proteins, some of the 
antibodies showed altered localization of 
immunosignals (examples in Fig. 3C-E and 
summarized in Fig. 2J). These results suggest that 
biochemically distinctive multiple populations of the 
antigens exist in cells, and that it is possible to identify 
individual localizations of the scaffold proteins by 
separating these populations. 
 
Molecular composition of the functional scaffold for 
the nucleus 
 
Antigens for the obtained antibodies were identified by 
the following methods: 1) cDNA expression library 
screening; 2) immunoprecipitation followed by the 
mass spectrometry analysis (Fig. 4); and 3) 
comparative analysis of immunoblotting band pattern 
with previously identified HeLa nuclear matrix 
proteins or highly insoluble rat liver proteins 
fractionated by reverse-phase HPLC (Fig. 5) [5, 6] 
(Table 1). The direct reactivity of each antibody 
against antigen was verified by Western blot using 
recombinant antigenic proteins. Many of them were 
already known to serve as functional scaffolds, such as 
scaffold attachment factor A (SAF-A), which functions 
as chromatin scaffold by binding to a scaffold 
attachment region of genomic DNA [12], and nuclear 
mitotic apparatus protein (NuMA), which is an 
essential protein for both interphase and mitotic 
chromatin organization [13]. A number of cytoskeletal 
components were identified, especially that of 
intermediate filaments including lamins, keratins, and 
vimentin. The large number of identified intermediate 
filament components is reasonable, because 
intermediate filaments are known to be the most 
biochemically stable structures among cytoskeletons. 
Interestingly, multiple numbers of monoclonal 
antibodies were found to recognize the same protein, 
Fig. 4 Identification of 5-42A 
antigen by immuno- 
precipitation and verification 
by Western blot. 
(A) Immunostaining of HeLa 
cells with 5-42A antibody. Scale 
bar: 10 µm. (B) Western blot of 
5-42A immunoprecipitated 
proteins by 5-42A antibody. A 
band below 68kDa was IgG 
heavy chain. (C) Silver staining 
of 5-42A immunoprecipitated 
proteins. Two bands indicated 
by arrowheads were subjected to 
in-gel digestion and mass 
spectrometry, and identified as 
nucleolin. (D) Western blot 
analyses with 5-42A, 
anti-nucleolin, and anti-GFP 
antibodies against lysates of 
HeLa cells (lane 1) and HeLa 
cells expressing GFP-nucleolin 
(lane 2). Bands correspond to 




and many antibodies recognized keratins, nucleolin, 
and SAF-A, suggesting that these proteins have highly 
antigenic properties. 
 The most important outcome of our 
monoclonal antibody production effort is that several 
characteristic antibodies recognize the same antigens, 
but stain different parts/compartments within the cells. 
One such case is antibodies against actinins and 
keratins, which exhibited intriguing subcellular 
distributions. Antibodies 28C and 92B, both of which 
recognized actinin-4, exhibited cytoplasmic and 
nucleoplasmic signals, respectively, whereas the major 
population of actinin-4 detected by a polyclonal 
antibody largely co-localized with β-actin at the cell 
adhesion sites (Fig. 6). This is in a strong contrast to 
the case of nucleolin; the immunolocalizations by 
many anti-nucleolin antibodies were almost the same. 
The epitopes of the monoclonal antibodies 28C and 
92B were shown to overlap with vinculin-binding site 
of actinin-4, suggesting that only a vinculin-free 
population of actinin-4 molecules is recognized by 
these antibodies [10]. The antibodies against keratins 
also showed distinct, either cytoplasmic or filamentous, 
immunolocalizations (Table 1). The antibodies 
obtained in this study will provide important clues in 
the future research of subcellular dynamics of scaffold 
proteins. 
 
CRM1-dependent nuclear shuttling of cytoskeletal 
proteins 
 
Complementary DNAs encoding actinin-4, βI-spectrin, 
keratin-7, -8, -17, -18, and vimentin were cloned into 











Fig. 5 Identification of 28C 
antigen by western blot 
against fractionated nuclear 
matrix proteins. 
(A) Nuclear matrix fraction was 
separated by reverse-phase 
HPLC in 60% formic acid and 
SDS-PAGE. Five to ten 
fractions were combined and 
loaded. (B) Western blot 
analysis of 28C antibody against 
fractionated nuclear matrix 
proteins. A band was detected in 
a lane 108-113. (C) The 
fractions 109 to 113 was 
separately loaded and subjected 
to the Western blot by 28C. (D) 
Silver staining image of the 
fractions 109 to 113. The band 
had been identified as actinin-4 
in our previous study [4]. (E) 
Verification by Western blot. 
His-tagged recombinant 
actinin-4 (lane 1), HeLa nuclear 
matrix proteins (lane 2), and 
BSA (lane 3) was loaded on 
SDS-PAGE and immunoblotted 




HeLa cells. All of them showed cytoplasmic 
filamentous distributions and did not show apparent 
nuclear localizations (Fig. 7A). Leptomycin B (LMB) 
is an inhibitor for CRM1, a nuclear export-mediator 
that exports a wide range of proteins containing a 
nuclear export signal (NES) [14]. When the HeLa cells 
were treated with LMB, some of these GFP-fusion 
proteins exhibited nuclear signals (Fig. 7B). More than 
50% of the cells exhibited strong nuclear 
accumulations of GFP-fused actinin-4 and keratin-8. 
Moreover, slightly increased nuclear signals were 
found for keratin-7, -17 and -18, whereas βI-spectrin 
and vimentin did not exhibit detectable nuclear signals 
at these experimental conditions. These nuclear 
accumulations did not result from the digestion or 
degradation of the GFP-fused proteins, as the apparent 
size of the GFP-fused proteins did not change after the 
LMB treatment as shown by the Western blot (Fig. 7C). 
Keratin-8 and -18 contain the following NES-like 
sequences: LMNVKLALDI (keratin-8, 377-386 amino 
acid residues) and LRRTVQSLEI (keratin-18, 
299-308). When the GFP-fused keratin-8 and -18 
lacking the NES-containing portion were expressed in 
HeLa cells, they showed obvious nuclear signals (Fig. 
7D). This suggests the nuclear targeting property of the 
N-terminus part of keratins. Actinin-4 exhibited the 
same property [10]. Fluorescent recovery after 
photobleaching (FRAP) analysis revealed their nuclear 
shuttling properties after bleaching the entire nuclear 
signals (Fig. 7E). They exhibited significant 
fluorescent recovery during the observation time, 
demonstrating their continuous exchange through the 
nuclear pore (Fig. 7F). To summarize, several 
cytoskeletal scaffold components are actively shuttling 
in and out of the nucleus, and are exported by the 
CRM1-dependent pathway. 
 
Nuclear keratins: filamentous vs. non-filamentous 




Fig. 6 Antibodies against actinins.  
(A) Specificity for 28C and 92B against actinin-1 
and actinin-4. His-tagged actinin-1 and actinin-4 
were expressed in E. coli and applied for 
immunodetection. (B) Immunostaining results of 
HeLa cells by 28C, 92B, anti-actinin-4 polyclonal 
antibody, and anti-β-actin antibodies. Scale bars: 10 
µm. 
There are 20 subtypes of keratin genes in humans and 
their expression is regulated in a cell type-specific 
manner [15]. Keratin-7, -8, -17, and -18 are known to 
be expressed in HeLa cells. Both antibodies 1-21A and 
2-40D specifically recognized keratin-8 on Western 
blot, but exhibited different immunolocalizations by 
cell staining; 2-40D recognized a structure that was 
obviously filamentous, whereas 1-21A exhibited 
cytoplasmic localization (Fig. 8A,B). When the cells 
were pre-treated with LMB, only the antibodies that 
recognized non-filamentous cytosolic keratins showed 
nuclear signals (Fig. 8C). The antibodies specific to 
filamentous keratins did not exhibit nuclear signals 
after the LMB treatment, suggesting that nuclear 
keratins do not take the filamentous form identical to 
their cytoskeletal state. When the soluble fraction of 
proteins was removed from the cells by the buffer 
containing 0.5% Triton X-100 after LMB treatment, 
the nuclear signals were not detected. 1-21A antibody 
exhibited filamentous signals in the 0.5% Triton 
X-100-treated cells, indicating that this antibody 
recognizes both filamentous and non-filamentous 
forms of keratin-8. These findings reveal the 






The spectrum of the antigens recognized by our 
monoclonal antibodies largely overlapped with the 
components of nuclear matrix and mitotic 
chromosomal proteins identified by mass spectrometry 
(Table 1). These monoclonal antibodies obtained in 
this research will be useful to complement the 
proteomic research by providing molecular insights 
into the subcellular scaffolds. On the other hand, we 
did not obtain any antibodies against abundant proteins 
such as actin and tubulins, which are expected to be 
enriched in immunogens. Most of the identified 
antigens contain characteristic α-helix-based structural 
motifs such as coiled-coil and spectrin-repeat, which 
are the assemblies of double and triple α-helices (Table 
1). We propose that such helix-based structures are 
highly antigenic. Anti-TCOF1 monoclonal antibody 
was generated previously from a mass production of 
monoclonal antibodies against hNopp140-associated 
proteins [16], also suggesting that this protein has 
highly antigenic properties. Although the immunogens 
might contain contamination of cytoplasmic proteins 
and some antibodies might be raised against those 
contaminations, we found many useful antibodies to 
reveal novel molecular dynamics in the nucleus. In 
addition, such antibodies uncover filamentous or 
non-filamentous molecular states of the antigens 
because of their monoclonalities, which correlated to 
the cytoplasmic and nuclear localizations of the 
antigens. These findings reconfirm the utility of the 
monoclonal antibodies which recognize specific 
molecular states, even they exhibits apparently 
unexpected immunofluorescence localizations. 
Molecular mechanisms for the nuclear 
transport of macromolecules through the nuclear pore 
complex (NPC) had been described as size-filtering 
diffusion and karyopherin-dependent active transport 
[17]. The classical nuclear localization signal (NLS) 
serves as a general signal sequence that is recognized 
by importin-α/β for transport into the nucleus [18]. 
However, most of the cytoskeletal proteins identified 
as antigens, such as actinin and keratins, are larger than 
the diffusion limit and do not contain apparent NLS  
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Fig. 7 CRM1-dependent nuclear localization of cytoskeletal components. 
(A) GFP-fused cytoskeletal components were expressed in HeLa cells and the localization of fluorescent 
signals were observed 36 hours after transfection. Scale bars: 10 µm. (B) Subcellular localization of GFP-fused 
cytoskeletal components in HeLa cells treated with 20 ng/ml Leptomycin B for 24 hours before observation. 
(C) Western blot analysis of HeLa cell lysate expressing GFP-fused proteins with an anti-GFP antibody. *: 
full-length, **: degradation product. (D) Subcellular localization of GFP-fused keratin-8 and -18 lacking 
NES-containing portions. Scale bars: 10 µm. (E) Snapshots of FRAP analysis. Nuclear population of 
GFP-keratin-8 ΔNES (1-376) was bleached and the fluorescent recovery was recorded. The targeted cell was 
indicated by an arrow. The images represents pre-bleach (left), immediately after bleach (middle) and 600 
seconds after bleach (right). Images are shown in gray (upper panels) and rainbow (lower panels) scales. (F) 
Quantitative analysis of fluorescent recoveries of GFP-keratin-8 ΔNES (K8ΔNES) and GFP-keratin-18 ΔNES 




consensus sequences. The nuclear localization of these 
helix-based cytoskeletal proteins is due partly to their 
amphiphilic properties that enable spontaneous 
nucleocytoplasmic shuttling. Hydrophobic interactions 
of amphiphilic α-helices are one of the driving forces 
for configuring the coiled-coil and spectrin-repeat 
structures [19, 20]. The NPC forms a hydrophobic 
barrier inside the pore with its hydrophobic subunits to 
prevent free diffusion of large macromolecules through 
the pore [21]. In addition to the passive diffusion and 
karyopherin-dependent transport, several amphiphilic 
molecules spontaneously pass through the NPC in a 
karyopherin-independent manner [22], possibly by 
exposing hydrophobic amino acid residues on the outer 
surface of the molecule to adapt to the hydrophobic 
environment inside the NPC. It is assumed that this 
selective permeability of the NPC enables dynamic 
molecular exchange of helix-based scaffold proteins 
between cytoplasm and nucleoplasm. 
 In this study we demonstrated 
CRM1-dependent nuclear shuttling of several 
cytoskeletal proteins, though some proteins were 
shown to be insensitive to LMB treatment (Fig. 7). 
Some cytoskeletal proteins were known to shuttle into 
the nucleus with another transport mediator. One 
protein is actin, one of the main cytoskeletal 
components, which is also known to shuttle into the 
nucleus to play a variety of roles in the nucleus. 
Although actin contains NES consensus sequences, its 

























Fig. 8 Nuclear localization of 
non-filamentous keratin-8. 
(A) Western blot analysis of 
monoclonal antibodies 1-21A, 
2-40D, and anti-GFP antibody 
against E. coli lysate 
expressing GFP-keratin-7, -8, 
-17, and -18. (B) Immuno- 
fluorescence staining of HeLa 
cells with 1-21A and 2-40D 
antibodies. (C) Immuno- 
staining of non-treated, LMB- 
treated (20 ng/ml, 2 hours), 
and LMB- and buffer A- 
treated HeLa cells with 1-21A 
and 2-40D antibodies. Scale 
bars: 10 µm. 
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exportin-6-dependent manner [23]. A variety of nuclear 
transport mediators would dynamically contribute to 
the spatiotemporal localization of scaffold proteins, 
reflecting the changing cellular requirements. 
 Besides its role as a physical scaffold for 
cells, cytoskeleton functions as a platform for many 
molecular interactions in the cytoplasm. The 
nuclear-localizing cytoskeletal components may also 
serve as a hub for the nuclear protein interactions. 
Interestingly, the nuclear populations of the shuttling 
proteins do not exhibit the same biochemical properties 
as their cytoskeletal states. For example, the nuclear 
keratin-8 was eluted by the detergent treatment (Fig. 8), 
demonstrating the highly soluble state of its nuclear 
population. Although the precise mechanisms 
regulating cytoskeletal protein molecular status in the 
nucleus remain unknown, their high solubility may be 
related to their role in the nucleus, such as, for example, 
the regulation of enzymatic reactions. 
 Contrary to actin filaments and microtubules, 
molecular events related to intermediate filaments have 
been described in less detail, possibly due to their 
highly insoluble properties, which prevent the use of 
typical molecular and biochemical approaches. Our 
antibody-based approach revealed the two distinctive 
populations of keratins as well as the nuclear 
localization of soluble keratins (Fig. 8). It has been 
reported that there are two distinctive populations of 
keratins, filamentous and free cytosolic pool, and that 
their dynamics, including the formation of the filament 
and their turn over, are regulated by specific 
phosphorylation [24, 25]. It is tempting to speculate 
what nuclear-specific keratin modification regulates its 
targeting and function in the nucleus. One example of a 
keratin whose role in the nucleus is known is 
keratin-17; it is involved in the Akt/mTOR signaling 
pathway by interacting with 14-3-3σ and it modulates 
the nucleocytoplasmic distribution of 14-3-3σ and 
regulates protein synthesis and cell growth [26]. Future 
studies will further examine the role of nuclear keratins 
in signal transduction, presumably by studying their 
interactions with nuclear factors. 
 As cytoskeletal organization serves as a 
sensor of extracellular environments, it is likely that 
dynamic nucleocytoplasmic shuttling of cytoskeletal 
components, including keratins, is important to 
orchestrate various cellular functions to achieve both 
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